Doctor profile · Federal record
Dr. Jessica Altman, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Chicago, IL
- NPI 1831391200
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 25 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
676 N Saint Clair St, Suite 850
Chicago, IL 606112927
(312) 695-4125 - Mailing address
-
303 East Superior Street, Room 5-111
Chicago, IL 60611
Credentials & registration
- NPI registered
- June 2007 — 19 yrs on file
- Profile last updated
- November 12, 2013
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Illinois #036111034
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1831391200. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
53,542
Distinct HCPCS
10
Medicare allowed
$1,800,622
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9299 |
Injection, nivolumab, 1 mg | 14,544 | 20 | $30 | |
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,180 | 28 | $48 | |
J9271 |
Injection, pembrolizumab, 1 mg | 7,200 | 23 | $54 | |
J1453 |
Injection, fosaprepitant, 1 mg | 6,300 | 30 | $0 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,110 | 35 | $44 | |
J9047 |
Injection, carfilzomib, 1 mg | 2,718 | 15 | $46 | |
J0897 |
Injection, denosumab, 1 mg | 2,100 | 14 | $23 | |
J9041 |
Injection, bortezomib, 0.1 mg | 1,749 | 30 | $4 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,421 | 17 | $28 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 938 | 44 | $0 |
In context: peer comparison
Among 77 peers in Chicago Hematology & Oncology Physician, average services per provider: 870. This provider delivers 62× the peer median.Open Payments
Industry payments received
All-time total
$17,034
Transactions
20
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma Europe LTD | 4 | $11,722.18 | |
| Daiichi Sankyo INC. | 7 | $4,623.20 | |
| Astellas Pharma US INC | 3 | $237.13 | |
| Abbvie INC. | 1 | $149.71 | |
| Jazz Pharmaceuticals INC. | 1 | $143.43 | |
| Astellas Pharma INC | 1 | $59.23 | |
| Celgene Corporation | 2 | $55.13 | |
| Genentech USA, INC. | 1 | $44.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
126
Patients
25
Total drug cost
$194,048
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Allopurinol | Generic | 34 | 0 | $396 |
| Venclexta (Venetoclax) | Brand | 30 | 13 | $51,971 |
| Acyclovir | Generic | 27 | 12 | $509 |
| Levofloxacin | Generic | 23 | 0 | $678 |
| Sprycel (Dasatinib) | Brand | 12 | 0 | $140,494 |
Hospital affiliations
Frequently asked questions
What is Dr. Jessica Altman's medical specialty?
Dr. Jessica Altman practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Jessica Altman practice?
Dr. Jessica Altman practices at 676 N Saint Clair St, Chicago, IL 606112927. Office phone: 3126954125.
What is Dr. Jessica Altman's NPI?
Dr. Jessica Altman's National Provider Identifier (NPI) is 1831391200, issued by NPPES.
Does Dr. Jessica Altman accept Medicare assignment?
Yes. Dr. Jessica Altman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jessica Altman commonly perform?
Top Medicare-reported procedures in 2023: Injection, nivolumab, 1 mg (HCPCS J9299); Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.